{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:45:08Z","timestamp":1793141108753,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06683-1","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T17:02:37Z","timestamp":1659200557000},"page":"43-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Anti\u2013m\u00fcllerian hormone as a predictor for live birth among women undergoing IVF\/ICSI in different age groups: an update of systematic review and meta-analysis"],"prefix":"10.1007","volume":"308","author":[{"given":"Ni-jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qiong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-8144","authenticated-orcid":false,"given":"Yu-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"3","key":"6683_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","volume":"88","author":"DB Seifer","year":"2007","unstructured":"Seifer DB, Maclaughlin DT (2007) Mullerian Inhibiting Substance Is An Ovarian Growth Factor Of Emerging Clinical Significance. Fertil Steril 88(3):539\u2013546","journal-title":"Fertil Steril"},{"issue":"3","key":"6683_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humrep\/der446","volume":"27","author":"SM Nelson","year":"2012","unstructured":"Nelson SM, Anderson RA, Broekmans FJ et al (2012) Anti-M\u00fcllerian hormone: clairvoyance or crystal clear? Hum Reprod (Oxf, Engl) 27(3):631\u2013636","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"11","key":"6683_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","volume":"111","author":"S Muttukrishna","year":"2004","unstructured":"Muttukrishna S, Suharjono H, McGarrigle H et al (2004) Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF\/ICSI patients? BJOG 111(11):1248\u20131253","journal-title":"BJOG"},{"issue":"2","key":"6683_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D et al (2010) Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16(2):113\u2013130","journal-title":"Hum Reprod Update"},{"issue":"10","key":"6683_CR5","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","volume":"112","author":"S Muttukrishna","year":"2005","unstructured":"Muttukrishna S, McGarrigle H, Wakim R et al (2005) Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112(10):1384\u20131390","journal-title":"BJOG"},{"issue":"10","key":"6683_CR6","first-page":"3836","volume":"84","author":"E Rajpert-De Meyts","year":"1999","unstructured":"Rajpert-De Meyts E, J\u00f8rgensen N, Graem N et al (1999) Expression of anti-M\u00fcllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84(10):3836\u20133844","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6683_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD (2010) Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 139(5):825\u2013833","journal-title":"Reproduction"},{"issue":"4","key":"6683_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmu003","volume":"20","author":"S Iliodromiti","year":"2014","unstructured":"Iliodromiti S, Kelsey TW, Wu O et al (2014) The predictive accuracy of anti-M\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update 20(4):560\u2013570","journal-title":"Hum Reprod Update"},{"issue":"1","key":"6683_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ et al (2015) Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril 103(1):119\u201330.e3","journal-title":"Fertil Steril"},{"issue":"6","key":"6683_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.rbmo.2010.06.041","volume":"21","author":"JG Wang","year":"2010","unstructured":"Wang JG, Douglas NC, Nakhuda GS et al (2010) The association between anti-M\u00fcllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online 21(6):757\u2013761","journal-title":"Reprod Biomed Online"},{"key":"6683_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"issue":"8","key":"6683_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"key":"6683_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.593216","volume":"11","author":"AM Kotlyar","year":"2020","unstructured":"Kotlyar AM, Seifer DB (2020) Ethnicity\/race and age-specific variations of serum AMH in women-a review. Front Endocrinol 11:593216","journal-title":"Front Endocrinol"},{"issue":"12","key":"6683_CR14","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/humrep\/der302","volume":"26","author":"SJ Liang","year":"2011","unstructured":"Liang SJ, Hsu CS, Tzeng CR et al (2011) Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod (Oxf, Engl) 26(12):3443\u20133449","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"7","key":"6683_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/humrep\/der134","volume":"26","author":"A Weghofer","year":"2011","unstructured":"Weghofer A, Dietrich W, Barad DH et al (2011) Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod (Oxf, Engl) 26(7):1905\u20131909","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"5","key":"6683_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10815-013-9973-5","volume":"30","author":"WQ Lin","year":"2013","unstructured":"Lin WQ, Yao LN, Zhang DX et al (2013) The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). J Assist Reprod Genet 30(5):649\u2013655","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"6683_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","volume":"30","author":"MF Mutlu","year":"2013","unstructured":"Mutlu MF, Erdem M, Erdem A et al (2013) Antral follicle count determines poor ovarian response better than anti-M\u00fcllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet 30(5):657\u2013665","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"6683_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","volume":"14","author":"K Lukaszuk","year":"2014","unstructured":"Lukaszuk K, Liss J, Kunicki M et al (2014) Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol 14(3):176\u2013181","journal-title":"Reprod Biol"},{"issue":"3 SUPPL. 1","key":"6683_CR19","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.fertnstert.2013.01.063","volume":"99","author":"L Li","year":"2013","unstructured":"Li L, Chenette P (2013) Predictors of mature oocytes in non-infertile women undergoing fertility preservation. Fertil Steril 99(3 SUPPL. 1):S29","journal-title":"Fertil Steril"},{"issue":"10","key":"6683_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108493","volume":"9","author":"HW Li","year":"2014","unstructured":"Li HW, Lee VC, Lau EY et al (2014) Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. PLoS ONE 9(10):e108493","journal-title":"PLoS ONE"},{"issue":"3","key":"6683_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.fertnstert.2016.12.013","volume":"107","author":"E Stochino-Loi","year":"2017","unstructured":"Stochino-Loi E, Darwish B, Mircea O et al (2017) Does preoperative antim\u00fcllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 107(3):707\u201313.e3","journal-title":"Fertil Steril"},{"issue":"5","key":"6683_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/01443615.2018.1552669","volume":"39","author":"CD McCormack","year":"2019","unstructured":"McCormack CD, Leemaqz SY, Furness DL et al (2019) Anti-M\u00fcllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes. J Obstet Gynaecol 39(5):623\u2013627","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"6683_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","volume":"109","author":"R Tal","year":"2018","unstructured":"Tal R, Seifer DB, Wantman E et al (2018) Antim\u00fcllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012\u20132013. Fertil Steril 109(2):258\u2013265","journal-title":"Fertil Steril"},{"issue":"1","key":"6683_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.fertnstert.2019.03.022","volume":"112","author":"S Ligon","year":"2019","unstructured":"Ligon S, Lustik M, Levy G et al (2019) Low Antim\u00fcllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant. Fertil Steril 112(1):73-81.e1","journal-title":"Fertil Steril"},{"issue":"4","key":"6683_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","volume":"104","author":"O Hamdine","year":"2015","unstructured":"Hamdine O, Eijkemans MJC, Lentjes EGW et al (2015) Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril 104(4):891\u20138.e2","journal-title":"Fertil Steril"},{"issue":"8","key":"6683_CR26","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/dey238","volume":"33","author":"SJ Morin","year":"2018","unstructured":"Morin SJ, Patounakis G, Juneau CR et al (2018) Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod (Oxf, Engl) 33(8):1489\u20131498","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"7\u20138","key":"6683_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.gyobfe.2012.02.001","volume":"40","author":"V Grzegorczyk-Martin","year":"2012","unstructured":"Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S et al (2012) Low circulating anti-M\u00fcllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program? Gynecol Obstet Fertil 40(7\u20138):411\u2013418","journal-title":"Gynecol Obstet Fertil"},{"issue":"5","key":"6683_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1479-828X.2011.01374.x","volume":"51","author":"B Frid\u00e9n","year":"2011","unstructured":"Frid\u00e9n B, Sj\u00f6blom P, Menezes J (2011) Using anti-M\u00fcllerian hormone to identify a good prognosis group in women of advanced reproductive age. Aust N Z J Obstet Gynaecol 51(5):411\u2013415","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"6683_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejogrb.2017.12.047","volume":"221","author":"Y Lee","year":"2018","unstructured":"Lee Y, Kim TH, Park JK et al (2018) Predictive value of antral follicle count and serum anti-M\u00fcllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol 221:151\u2013155","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"6683_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2217\/whe.15.102","volume":"12","author":"N Pereira","year":"2016","unstructured":"Pereira N, Setton R, Petrini AC et al (2016) Is anti-M\u00fcllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve? Womens Health (Lond) 12(2):185\u2013192","journal-title":"Womens Health (Lond)"},{"issue":"13","key":"6683_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006495","volume":"96","author":"H Zheng","year":"2017","unstructured":"Zheng H, Chen S, Du H et al (2017) Ovarian response prediction in controlled ovarian stimulation for IVF using anti-M\u00fcllerian hormone in Chinese women: a retrospective cohort study. Medicine (Baltimore) 96(13):e6495","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6683_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11596-018-1954-6","volume":"38","author":"XL Li","year":"2018","unstructured":"Li XL, Huang R, Fang C et al (2018) Basal serum Anti-M\u00fcllerian Hormone level as a predictor of clinical outcomes in freezing-all embryo transfer program. Curr Med Sci 38(5):861\u2013867","journal-title":"Curr Med Sci"},{"issue":"3","key":"6683_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.rbmo.2019.04.011","volume":"39","author":"L Preaubert","year":"2019","unstructured":"Preaubert L, Shaulov T, Phillips S et al (2019) Live birth rates remain stable in modified natural IVF despite low anti-M\u00fcllerian hormone: analysis of 638 cycles. Reprod Biomed Online 39(3):461\u2013466","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"6683_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1757-2215-6-3","volume":"6","author":"A Khader","year":"2013","unstructured":"Khader A, Lloyd SM, McConnachie A et al (2013) External validation of anti-M\u00fcllerian hormone based prediction of live birth in assisted conception. J Ovarian Res 6(1):3","journal-title":"J Ovarian Res"},{"issue":"sup1","key":"6683_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/09513590.2017.1399692","volume":"33","author":"A Amsiejiene","year":"2017","unstructured":"Amsiejiene A, Drasutiene G, Usoniene A et al (2017) The influence of age, body mass index, waist-to-hip ratio and anti-Mullerian hormone level on clinical pregnancy rates in ART. Gynecol Endocrinol 33(sup1):41\u201343","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"6683_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.fertnstert.2017.07.001","volume":"108","author":"B Tarasconi","year":"2017","unstructured":"Tarasconi B, Tadros T, Ayoubi JM et al (2017) Serum Antim\u00fcllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertil Steril 108(3):518\u2013524","journal-title":"Fertil Steril"},{"issue":"1","key":"6683_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12958-019-0498-3","volume":"17","author":"B Zhang","year":"2019","unstructured":"Zhang B, Meng Y, Jiang X et al (2019) IVF outcomes of women with discrepancies between age and serum anti-M\u00fcllerian hormone levels. Reprod Biol Endocrinol 17(1):58","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"6683_CR38","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R (2007) Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy. Hum Reprod (Oxf, Engl) 22(9):2414\u20132421","journal-title":"Hum Reprod (Oxf, Engl)"},{"key":"6683_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1477-7827-7-100","volume":"7","author":"TH Lee","year":"2009","unstructured":"Lee TH, Liu CH, Huang CC et al (2009) Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reprod Biol Endocrinol 7:100","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"6683_CR40","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","volume":"94","author":"N Gleicher","year":"2010","unstructured":"Gleicher N, Weghofer A, Barad DH (2010) Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 94(7):2824\u20132827","journal-title":"Fertil Steril"},{"issue":"2","key":"6683_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","volume":"150","author":"K Majumder","year":"2010","unstructured":"Majumder K, Gelbaya TA, Laing I et al (2010) The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol 150(2):166\u2013170","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"6683_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","volume":"22","author":"A La Marca","year":"2011","unstructured":"La Marca A, Nelson SM, Sighinolfi G et al (2011) Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online 22(4):341\u2013349","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"6683_CR43","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2012-3676","volume":"98","author":"T Brodin","year":"2013","unstructured":"Brodin T, Hadziosmanovic N, Berglund L et al (2013) Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab 98(3):1107\u20131114","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6683_CR44","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","volume":"30","author":"Z Merhi","year":"2013","unstructured":"Merhi Z, Zapantis A, Berger DS et al (2013) Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve. J Assist Reprod Genet 30(10):1361\u20131365","journal-title":"J Assist Reprod Genet"},{"key":"6683_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejogrb.2016.02.007","volume":"200","author":"IF Reijnders","year":"2016","unstructured":"Reijnders IF, Nelen WL, IntHout J et al (2016) The value of Anti-M\u00fcllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 200:45\u201350","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"6683_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","volume":"17","author":"K Keane","year":"2017","unstructured":"Keane K, Cruzat VF, Wagle S et al (2017) Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol 17(1):51\u201359","journal-title":"Reprod Biol"},{"key":"6683_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","volume":"225","author":"SSE Alson","year":"2018","unstructured":"Alson SSE, Bungum LJ, Giwercman A et al (2018) Anti-m\u00fcllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-m\u00fcllerian hormone is modest. Eur J Obstet Gynecol Reprod Biol 225:199\u2013204","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"6683_CR48","first-page":"402","volume":"23","author":"JL Metello","year":"2019","unstructured":"Metello JL, Tom\u00e1s C, Ferreira P (2019) Can we predict the IVF\/ICSI live birth rate? JBRA Assist Reprod 23(4):402\u2013407","journal-title":"JBRA Assist Reprod"},{"issue":"1","key":"6683_CR49","doi-asserted-by":"publisher","first-page":"19750","DOI":"10.1038\/s41598-020-76543-y","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Wang Y, Yang H et al (2020) AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles. Sci Rep 10(1):19750","journal-title":"Sci Rep"},{"issue":"3","key":"6683_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/humrep\/deaa008","volume":"35","author":"P Peuranp\u00e4\u00e4","year":"2020","unstructured":"Peuranp\u00e4\u00e4 P, Hautam\u00e4ki H, Halttunen-Nieminen M et al (2020) Low anti-M\u00fcllerian hormone level is not a risk factor for early pregnancy loss in IVF\/ICSI treatment. Hum Reprod (Oxf, Engl) 35(3):504\u2013515","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"6","key":"6683_CR51","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"JC Arce","year":"2013","unstructured":"Arce JC, La Marca A, Mirner Klein B et al (2013) Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril 99(6):1644\u20131653","journal-title":"Fertil Steril"},{"issue":"2","key":"6683_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejogrb.2013.01.013","volume":"168","author":"K Lukaszuk","year":"2013","unstructured":"Lukaszuk K, Kunicki M, Liss J et al (2013) Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 168(2):173\u2013177","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"6683_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.fertnstert.2015.10.004","volume":"105","author":"DB Seifer","year":"2016","unstructured":"Seifer DB, Tal O, Wantman E et al (2016) Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antim\u00fcllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012\u20132013. Fertil Steril 105(2):385\u201393.e3","journal-title":"Fertil Steril"},{"issue":"7251","key":"6683_CR54","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","volume":"320","author":"AM Nybo Andersen","year":"2000","unstructured":"Nybo Andersen AM, Wohlfahrt J, Christens P et al (2000) Maternal age and fetal loss: population based register linkage study. BMJ 320(7251):1708\u20131712","journal-title":"BMJ"},{"issue":"1","key":"6683_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","volume":"87","author":"JM Smeenk","year":"2007","unstructured":"Smeenk JM, Sweep FC, Zielhuis GA et al (2007) Antim\u00fcllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril 87(1):223\u2013226","journal-title":"Fertil Steril"},{"issue":"5","key":"6683_CR56","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","volume":"16","author":"S Lie Fong","year":"2008","unstructured":"Lie Fong S, Baart EB, Martini E et al (2008) Anti-M\u00fcllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 16(5):664\u2013670","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"6683_CR57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ando.2009.03.007","volume":"70","author":"F Guerif","year":"2009","unstructured":"Guerif F, Lemseffer M, Couet M et al (2009) Serum antim\u00fcllerian hormone is not predictive of oocyte quality in vitro fertilization. Ann Endocrinol (Paris) 70(4):230\u2013234","journal-title":"Ann Endocrinol (Paris)"},{"issue":"7","key":"6683_CR58","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.fertnstert.2009.01.125","volume":"93","author":"R Mashiach","year":"2010","unstructured":"Mashiach R, Amit A, Hasson J et al (2010) Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril 93(7):2299\u20132302","journal-title":"Fertil Steril"},{"issue":"1","key":"6683_CR59","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.fertnstert.2010.07.1042","volume":"95","author":"R Riggs","year":"2011","unstructured":"Riggs R, Kimble T, Oehninger S et al (2011) Anti-M\u00fcllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril 95(1):410\u2013412","journal-title":"Fertil Steril"},{"issue":"6","key":"6683_CR60","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/humrep\/des101","volume":"27","author":"E Anckaert","year":"2012","unstructured":"Anckaert E, Smitz J, Schiettecatte J et al (2012) The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod (Oxf, Engl) 27(6):1829\u20131839","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"5","key":"6683_CR61","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.rbmo.2012.01.023","volume":"24","author":"A Kedem-Dickman","year":"2012","unstructured":"Kedem-Dickman A, Maman E, Yung Y et al (2012) Anti-M\u00fcllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes. Reprod Biomed Online 24(5):540\u2013546","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"6683_CR62","first-page":"322","volume":"35","author":"M Szafarowska","year":"2014","unstructured":"Szafarowska M, Molinska-Glura M, Jerzak MM (2014) Anti-M\u00fcllerian hormone concentration as a biomarker of pregnancy success or failure. Neuro Endocrinol Lett 35(4):322\u2013326","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"6683_CR63","first-page":"231","volume":"13","author":"GA Ayd\u0131n","year":"2015","unstructured":"Ayd\u0131n GA, Yavuz A, Terzi H et al (2015) Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI. Iran J Reprod Med 13(4):231\u2013236","journal-title":"Iran J Reprod Med"},{"issue":"1","key":"6683_CR64","first-page":"40","volume":"11","author":"JB Scheffer","year":"2017","unstructured":"Scheffer JB, Scheffer BB, de Carvalho RF et al (2017) Age as a predictor of embryo quality regardless of the quantitative ovarian response. Int J Fertil Steril 11(1):40\u201346","journal-title":"Int J Fertil Steril"},{"key":"6683_CR65","doi-asserted-by":"publisher","first-page":"205031211986513","DOI":"10.1177\/2050312119865137","volume":"7","author":"S Devi\u0107 Pavli\u0107","year":"2019","unstructured":"Devi\u0107 Pavli\u0107 S, Trami\u0161ak Milakovi\u0107 T, Pani\u0107 Horvat L et al (2019) Genes for anti-M\u00fcllerian hormone and androgen receptor are underexpressed in human cumulus cells surrounding morphologically highly graded oocytes. SAGE Open Med 7:2050312119865137","journal-title":"SAGE Open Med"},{"issue":"22","key":"6683_CR66","first-page":"11488","volume":"24","author":"A Pacchiarotti","year":"2020","unstructured":"Pacchiarotti A, Iaconianni P, Caporali S et al (2020) Severe endometriosis: low value of AMH did not affect oocyte quality and pregnancy outcome in IVF patients. Eur Rev Med Pharmacol Sci 24(22):11488\u201311495","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"6683_CR67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.23736\/S0026-4784.20.04546-3","volume":"72","author":"A Korkidakis","year":"2020","unstructured":"Korkidakis A, Cho KK, Albert A et al (2020) Anti-M\u00fcllerian hormone and embryo quality as determined by time-lapse imaging. Minerva Ginecol 72(3):132\u2013137","journal-title":"Minerva Ginecol"},{"issue":"8","key":"6683_CR68","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/humrep\/del127","volume":"21","author":"T Ebner","year":"2006","unstructured":"Ebner T, Sommergruber M, Moser M et al (2006) Basal level of anti-M\u00fcllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod (Oxf, Engl) 21(8):2022\u20132026","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"5","key":"6683_CR69","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00404-011-1979-6","volume":"284","author":"T Irez","year":"2011","unstructured":"Irez T, Ocal P, Guralp O et al (2011) Different serum anti-M\u00fcllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. Arch Gynecol Obstet 284(5):1295\u20131301","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"6683_CR70","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","volume":"31","author":"P Lehmann","year":"2014","unstructured":"Lehmann P, V\u00e9lez MP, Saumet J et al (2014) Anti-M\u00fcllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet 31(4):493\u2013498","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"6683_CR71","first-page":"1717","volume":"60","author":"HM Kamel","year":"2014","unstructured":"Kamel HM, Amin AH, Al-Adawy AR (2014) Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles. Clin Lab 60(10):1717\u20131723","journal-title":"Clin Lab"},{"issue":"3","key":"6683_CR72","first-page":"225","volume":"69","author":"L Melado Vidales","year":"2017","unstructured":"Melado Vidales L, Fern\u00e1ndez-Nistal A, Mart\u00ednez Fern\u00e1ndez V et al (2017) Anti-M\u00fcllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation. Minerva Ginecol 69(3):225\u2013232","journal-title":"Minerva Ginecol"},{"key":"6683_CR73","doi-asserted-by":"publisher","first-page":"1092415","DOI":"10.1155\/2019\/1092415","volume":"2019","author":"K Olszak-W\u0105sik","year":"2019","unstructured":"Olszak-W\u0105sik K, Bednarska-Czerwi\u0144ska A, Olejek A et al (2019) From \u201cevery day\u201d hormonal to oxidative stress biomarkers in blood and follicular fluid, to embryo quality and pregnancy success? Oxid Med Cell Longev 2019:1092415","journal-title":"Oxid Med Cell Longev"},{"key":"6683_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.theriogenology.2019.11.041","volume":"143","author":"K Karakas Alkan","year":"2020","unstructured":"Karakas Alkan K, Alkan H, Kaymaz M (2020) The effect of anti-m\u00fcllerian hormone and progesterone concentrations on superovulation response and embryo yield in goats. Theriogenology 143:1\u20139","journal-title":"Theriogenology"},{"issue":"2","key":"6683_CR75","first-page":"266","volume":"25","author":"TC Sun","year":"2021","unstructured":"Sun TC, Zhou SJ, Song LL et al (2021) High anti-M\u00fcllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF\/ICSI treatment. JBRA Assist Reprod 25(2):266\u2013271","journal-title":"JBRA Assist Reprod"},{"issue":"6","key":"6683_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099393","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shao L, Xu Y et al (2014) Effect of anti-Mullerian hormone in culture medium on quality of mouse oocytes matured in vitro. PLoS ONE 9(6):e99393","journal-title":"PLoS ONE"},{"issue":"9","key":"6683_CR77","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3346\/jkms.2014.29.9.1266","volume":"29","author":"JH Kim","year":"2014","unstructured":"Kim JH, Lee JR, Chang HJ et al (2014) Anti-M\u00fcllerian hormone levels in the follicular fluid of the preovulatory follicle: a predictor for oocyte fertilization and quality of embryo. J Korean Med Sci 29(9):1266\u20131270","journal-title":"J Korean Med Sci"},{"issue":"4","key":"6683_CR78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.rbmo.2010.05.009","volume":"21","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Giulini S et al (2010) Normal serum concentrations of anti-M\u00fcllerian hormone in women with regular menstrual cycles. Reprod Biomed Online 21(4):463\u2013469","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"6683_CR79","first-page":"24","volume":"10","author":"M Goswami","year":"2017","unstructured":"Goswami M, Nikolaou D (2017) Is AMH level, independent of age, a predictor of live birth in IVF? J Hum Reprod Sci 10(1):24\u201330","journal-title":"J Hum Reprod Sci"},{"issue":"7","key":"6683_CR80","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1210\/en.2005-1588","volume":"147","author":"ME Kevenaar","year":"2006","unstructured":"Kevenaar ME, Meerasahib MF, Kramer P et al (2006) Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147(7):3228\u20133234","journal-title":"Endocrinology"},{"issue":"12","key":"6683_CR81","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2012-1440","volume":"97","author":"S Lie Fong","year":"2012","unstructured":"Lie Fong S, Visser JA, Welt CK et al (2012) Serum Anti-M\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 97(12):4650\u20134655","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6683_CR82","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.rbmo.2019.11.013","volume":"40","author":"SM Nelson","year":"2020","unstructured":"Nelson SM, Aijun S, Ling Q et al (2020) Ethnic discordance in serum anti-M\u00fcllerian hormone in healthy women: a population study from China and Europe. Reprod Biomed Online 40(3):461\u2013467","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"6683_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","volume":"101","author":"ME Bleil","year":"2014","unstructured":"Bleil ME, Gregorich SE, Adler NE et al (2014) Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women. Fertil Steril 101(1):199\u2013207","journal-title":"Fertil Steril"},{"key":"6683_CR84","unstructured":"Cochrane (2013) Cochrane Handbook for DTA reviews."},{"issue":"2","key":"6683_CR85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2214\/AJR.06.0226","volume":"187","author":"C Gatsonis","year":"2006","unstructured":"Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 187(2):271\u2013281","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"6683_CR86","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1210\/jc.2006-0331","volume":"91","author":"WJ Hehenkamp","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen AP et al (2006) Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91(10):4057\u20134063","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6683_CR87","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.fertnstert.2013.10.021","volume":"101","author":"SM Nelson","year":"2014","unstructured":"Nelson SM, Iliodromiti S, Fleming R et al (2014) Reference range for the antim\u00fcllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram. Fertil Steril 101(2):523\u2013529","journal-title":"Fertil Steril"},{"key":"6683_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12958-015-0101-5","volume":"13","author":"J Hyldgaard","year":"2015","unstructured":"Hyldgaard J, Bor P, Ingerslev HJ et al (2015) Comparison of two different methods for measuring anti-mullerian hormone in a clinical series. Reprod Biol Endocrinol 13:107","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"6683_CR89","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/humrep\/deu036","volume":"29","author":"P Welsh","year":"2014","unstructured":"Welsh P, Smith K, Nelson SM (2014) A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Hum Reprod (Oxf, Engl) 29(5):1035\u20131041","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"6","key":"6683_CR90","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.clinbiochem.2014.12.023","volume":"48","author":"D Gruson","year":"2015","unstructured":"Gruson D, Homsak E (2015) Measurement of anti-Mullerian hormone: performances of a new ultrasensitive immunoassay. Clin Biochem 48(6):453\u2013455","journal-title":"Clin Biochem"},{"issue":"12","key":"6683_CR91","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A La Marca","year":"2006","unstructured":"La Marca A, Stabile G, Artenisio AC et al (2006) Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod (Oxf, Engl) 21(12):3103\u20133107","journal-title":"Hum Reprod (Oxf, Engl)"},{"issue":"7","key":"6683_CR92","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/dem101","volume":"22","author":"S Tsepelidis","year":"2007","unstructured":"Tsepelidis S, Devreker F, Demeestere I et al (2007) Stable serum levels of anti-M\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod (Oxf, Engl) 22(7):1837\u20131840","journal-title":"Hum Reprod (Oxf, Engl)"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06683-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:05:20Z","timestamp":1684325120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["6683"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06683-1","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No patient consent or ethical approval was required because analyses were based on previous published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}